This randomized, triple-blind, placebo-controlled study will evaluate the efficacy of Diaberine, a berberine-based nutraceutical, in aiding blood sugar regulation and metabolism in 80 participants over 24 weeks.
Male or female.
BMI: 27-35 kg/m2
HbA1c of 5.7%-6.4% (determined by prescreening blood test)
Be generally healthy
Diagnosed with Type 2 diabetes mellitus (T2DM) and have been prescribed metformin, insulin, Sulfonylureas, Meglitinides, SGLT2 inhibitors and/or GLP-1 medications including the following prescription medications: Wegovy (semaglutide), Ozempic (semaglutide), Rybelsus (semaglutide), Saxenda (liraglutide), Victoza (liraglutide), Zepbound (bimagrumab), Byetta (exenatide), Bydureon (exenatide ER), Trulicity (dulaglutide), Adlyxin (lixisenatide)
Current use or past history of use within the last 2 months (8 weeks) of the following prescription medications: Beta-blockers Sectral (Acebutolol), Tenormin (Atenolol), Kerlone, Betoptic (Betaxolol), Zebeta (Bisoprolol), Coreg, Coreg CR (Carvedilol), Trandate, Normodyne (Labetalol), Lopressor, Toprol XL (Metoprolol), Corgard (Nadolol), Bystolic (Nebivolol), Levatol (Penbutolol), Visken (Pindolol), Inderal, Inderal LA, InnoPran XL (Propranolol). Thiazide diuretics Diuril (Chlorothiazide), Microzide (Hydrochlorothiazide), Thalitone, Hygroton (Chlorthalidone), Lozol (Indapamide), Zaroxolyn (Metolazone), Naturetin (Bendroflumethiazide), Enduron (Methyclothiazide). Corticosteroids Deltasone (Prednisone), Orapred, Prelone (Prednisolone), Medrol (Methylprednisolone), Qvar (Beclomethasone), Celestone (Betamethasone), Decadron (Dexamethasone), Cortef (Hydrocortisone), Kenalog (Triamcinolone). Immunosuppressants Tacrolimus (Prograf), Cyclosporine (Neoral), Sirolimus (Rapamune)
Women who are pregnant, breastfeeding, or trying to conceive.
Anyone unwilling or unable to follow the study protocol.
Parallel
Diaberine
Dietary supplementParticipants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
Placebo Capsule
Dietary supplementParticipants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
Blood Sugar Regulation
Evaluation of the effect of Diaberine on blood sugar regulation as measured by changes in HbA1c
Metabolism
Evaluation of the effect of Diaberine on metabolism, as measured by changes in lipid panel levels.
Quality of Life change
Assessment of participant-reported quality of life via a questionnaire.
Weight Change
Evaluation of changes in participant weight.
Click on the lead sponsor to view all of their trials.
Ultimate International, Inc.
Lead sponsor
Citruslabs
Collaborator
